This statistic shows Biogen's selling, general and administrative (SG&A) costs from 2014 to 2024, in million U.S. dollars. SG&A costs stood at 2.4 billion U.S. dollars in 2024. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Biogen, & U.S. Securities and Exchange Commission. (February 14, 2025). Selling, general and administrative costs of Biogen from 2016 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 23, 2026, from /statistics/968229/biogen-selling-general-and-administrative-costs/
Biogen, und U.S. Securities and Exchange Commission. "Selling, general and administrative costs of Biogen from 2016 to 2024 (in million U.S. dollars)." Chart. February 14, 2025. ÌÇÐÄÆÆ½â°æ. Accessed July 23, 2026. /statistics/968229/biogen-selling-general-and-administrative-costs/
Biogen, U.S. Securities and Exchange Commission. (2025). Selling, general and administrative costs of Biogen from 2016 to 2024 (in million U.S. dollars). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 23, 2026. /statistics/968229/biogen-selling-general-and-administrative-costs/
Biogen, and U.S. Securities and Exchange Commission. "Selling, General and Administrative Costs of Biogen from 2016 to 2024 (in Million U.S. Dollars)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 14 Feb 2025, /statistics/968229/biogen-selling-general-and-administrative-costs/
Biogen & U.S. Securities and Exchange Commission, Selling, general and administrative costs of Biogen from 2016 to 2024 (in million U.S. dollars) ÌÇÐÄÆÆ½â°æ, /statistics/968229/biogen-selling-general-and-administrative-costs/ (last visited July 23, 2026)
Selling, general and administrative costs of Biogen from 2016 to 2024 (in million U.S. dollars) [Graph], Biogen, & U.S. Securities and Exchange Commission, February 14, 2025. [Online]. Available: /statistics/968229/biogen-selling-general-and-administrative-costs/